OUR PURPOSE IS SIMPLE:
Patients fighting chronic diseases are often denied access to life-saving treatments.
ICERWatch gives patients a voice to fight back.
Their kids have a rare and fatal disease. ICER President Dr. Steve Pearson believes Duchenne moms shouldn’t get a “vote” on their kids’ treatment.
Citing its impact on “health care insurance costs,” the Institute for Clinical and Economic Review has issued its dreaded insurance profitability “alert” for two new treatments for peanut allergies. ICER’s report encourages insurance companies to deny coverage and impose substantial barriers for patients seeking access to the treatments.
July is the month where we as a nation commemorate the Declaration of Independence of our country. On July 4, 1776 the Continental Congress declared
ICER uses quality-adjusted life years to calculate value and determine health care access. Here are 5 ways that the QALY formula is bad for patients.
The Institute for Clinical and Economic Review and its controversial “one-size-fits-all” value framework are a direct threat to patients living with rare diseases, an independent report warns.